Aortic Dissection: Clinical Trials

7 trials for Aortic Dissection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 withdrawn. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Terminated 2, Withdrawn 1

Follow Aortic Dissection: new trials by email Literature Review of Aortic Dissection trials Research Report on Aortic Dissection

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients
Nitric Oxide, Placebo - Acute Kidney Injury, Nitrous Oxide
Phase 4CompletedBeijing Anzhen Hospital1062024-11-302026-02-05
Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)
Methylprednisolone Injection - Methylprednisolone, Glucocorticoid
Phase 4CompletedShanghai Zhongshan Hospital2122022-02-072023-12-26
Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
recombinant human erythropoietin, saline - Dissection of Thoracic Aorta
Phase 4CompletedYonsei University662011-05-012013-09-26
Long-term Benefit of Aortic Stent-graft in Patients With Distal Aortic Dissection
Aortic stent-graft - Aortic Dissection, Aortic Aneurysm
Phase 4TerminatedAsan Medical Center72011-01-012015-01-14
ATLANTIS:Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal Aneurysms Repair With LupiAe Hybrid TechNique
lupiae technique - Aortic Aneurysm
Phase 4WithdrawnIRCCS Azienda Ospedaliero-Universitaria di Bologna1202010-06-012011-06-28
A Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT)
clevidipine. - Aortic Aneurysm, Aortic Disease
Phase 4TerminatedAsma Zainab, M.D.52009-11-012018-08-27
Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
celiprolol, Control - EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT, CHROMOSOME 2q31.2 DELETION SYNDROME
Phase 4CompletedAssistance Publique - Hôpitaux de Paris542003-10-012013-01-16

Narrower conditions

Aortic Aneurysm (3)  ·  Acute Kidney Injury (1)  ·  Aortic Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Chromosome 2q31.2 Deletion Syndrome (1)  ·  Dissection, Thoracic Aorta (1)  ·  Ehlers-Danlos Syndrome (1)  ·  Ehlers-Danlos Syndrome, Type IV (1)  ·  Emergencies (1)

Broader conditions

Aneurysm (7)  ·  Dissection, Blood Vessel (7)  ·  Vascular Diseases (7)  ·  Acute Aortic Syndrome (6)  ·  Cardiovascular Diseases (6)  ·  Aortic Diseases (5)  ·  Collagen Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Celiprolol (1)  ·  Methylprednisolone (1)  ·  Nitric Oxide (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  clevidipine (1)

Sponsors

Asan Medical Center (1)  ·  Asma Zainab, M.D. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beijing Anzhen Hospital (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Shanghai Zhongshan Hospital (1)  ·  Yonsei University (1)

Countries

China (2)  ·  South Korea (2)  ·  Italy (1)  ·  United States (1)

Top investigators

Asma Zainab, MD (1)  ·  Faisal Masud, MD (1)  ·  Yon Hee Shim (1)  ·  Zhe Luo, MD, PhD (1)

Results publications

PMID 20825986, PMID 40790609